Human Gene MIR31 (ENST00000362307.1) from GENCODE V44
  Description: Homo sapiens microRNA 31 (MIR31), microRNA. (from RefSeq NR_029505)
RefSeq Summary (NR_029505): microRNAs (miRNAs) are short (20-24 nt) non-coding RNAs that are involved in post-transcriptional regulation of gene expression in multicellular organisms by affecting both the stability and translation of mRNAs. miRNAs are transcribed by RNA polymerase II as part of capped and polyadenylated primary transcripts (pri-miRNAs) that can be either protein-coding or non-coding. The primary transcript is cleaved by the Drosha ribonuclease III enzyme to produce an approximately 70-nt stem-loop precursor miRNA (pre-miRNA), which is further cleaved by the cytoplasmic Dicer ribonuclease to generate the mature miRNA and antisense miRNA star (miRNA*) products. The mature miRNA is incorporated into a RNA-induced silencing complex (RISC), which recognizes target mRNAs through imperfect base pairing with the miRNA and most commonly results in translational inhibition or destabilization of the target mRNA. The RefSeq represents the predicted microRNA stem-loop. [provided by RefSeq, Sep 2009]. Sequence Note: This record represents a predicted microRNA stem-loop as defined by miRBase. Some sequence at the 5' and 3' ends may not be included in the intermediate precursor miRNA produced by Drosha cleavage.
Gencode Transcript: ENST00000362307.1
Gencode Gene: ENSG00000199177.1
Transcript (Including UTRs)
   Position: hg38 chr9:21,512,115-21,512,185 Size: 71 Total Exon Count: 1 Strand: -


Page IndexSequence and LinksPrimersCTDRNA-Seq ExpressionMicroarray Expression
Other SpeciesmRNA DescriptionsOther NamesMethods
Data last updated at UCSC: 2023-08-18 00:09:47

-  Sequence and Links to Tools and Databases
 
Genomic Sequence (chr9:21,512,115-21,512,185)mRNA (may differ from genome)No protein
Gene SorterGenome BrowserOther Species FASTAGene interactionsTable SchemaBioGPS
EnsemblEntrez GeneExonPrimerGencodeHGNCLynx
MalacardsOMIMPubMedBioGrid CRISPR DB

-  Primer design for this transcript
 

Primer3Plus can design qPCR Primers that straddle exon-exon-junctions, which amplify only cDNA, not genomic DNA.
Click here to load the transcript sequence and exon structure into Primer3Plus

Exonprimer can design one pair of Sanger sequencing primers around every exon, located in non-genic sequence.
Click here to open Exonprimer with this transcript

To design primers for a non-coding sequence, zoom to a region of interest and select from the drop-down menu: View > In External Tools > Primer3


-  Comparative Toxicogenomics Database (CTD)
  The following chemicals interact with this gene

-  RNA-Seq Expression Data from GTEx (53 Tissues, 570 Donors)
  Highest median expression: 0.00 RPKM in Adipose - Subcutaneous
Total median expression: 0.00 RPKM



View in GTEx track of Genome Browser    View at GTEx portal     View GTEx Body Map

+  Microarray Expression Data
  Press "+" in the title bar above to open this section.

-  Orthologous Genes in Other Species
  Orthologies between human, mouse, and rat are computed by taking the best BLASTP hit, and filtering out non-syntenic hits. For more distant species reciprocal-best BLASTP hits are used. Note that the absence of an ortholog in the table below may reflect incomplete annotations in the other species rather than a true absence of the orthologous gene.
MouseRatZebrafishD. melanogasterC. elegansS. cerevisiae
No orthologNo orthologNo orthologNo orthologNo orthologNo ortholog
      
      
      
      
      

-  Descriptions from all associated GenBank mRNAs
  CS266555 - Sequence 247 from Patent WO2005118806.
DL076717 - METHODS AND COMPOSITIONS INVOLVING MicroRNA.
DM004367 - METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
FW421709 - METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
HW367580 - JP 2012228254-A/247: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
HW411973 - JP 2014000079-A/247: METHODS AND COMPOSITIONS INVOLVING MicroRNA.
HW674319 - JP 2014217381-A/247: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
HZ067261 - JP 2014012020-A/247: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
HZ427685 - JP 2014217384-A/247: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
HZ428488 - JP 2014217385-A/247: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
HZ429291 - JP 2014217386-A/247: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
HZ430094 - JP 2014217387-A/247: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
HZ769351 - JP 2014223080-A/247: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
JA058745 - Sequence 247 from Patent EP2298893.
JA059548 - Sequence 247 from Patent EP2298894.
JA073871 - Sequence 247 from Patent EP2281887.
JA105008 - Sequence 247 from Patent EP2302051.
JA106348 - Sequence 247 from Patent EP2302052.
JA107151 - Sequence 247 from Patent EP2302053.
JA107954 - Sequence 247 from Patent EP2302054.
JA108757 - Sequence 247 from Patent EP2302055.
JA109560 - Sequence 247 from Patent EP2302056.
JA192076 - Sequence 247 from Patent EP2290066.
JA192975 - Sequence 247 from Patent EP2290067.
JA193874 - Sequence 247 from Patent EP2290068.
JA194773 - Sequence 247 from Patent EP2290069.
JA195672 - Sequence 247 from Patent EP2290070.
JA196571 - Sequence 247 from Patent EP2290071.
JA197470 - Sequence 247 from Patent EP2290072.
JA198369 - Sequence 247 from Patent EP2290073.
JA199268 - Sequence 247 from Patent EP2290074.
JA200167 - Sequence 247 from Patent EP2290075.
JA201066 - Sequence 247 from Patent EP2290076.
JA218188 - Sequence 247 from Patent EP2281888.
JA226339 - Sequence 247 from Patent EP2292755.
JA229194 - Sequence 247 from Patent EP2292756.
JA257465 - Sequence 247 from Patent EP2284265.
JA278745 - Sequence 247 from Patent EP2281886.
JA284631 - Sequence 247 from Patent EP2281889.
JA292684 - Sequence 247 from Patent EP2287303.
JA317870 - Sequence 247 from Patent EP2314688.
JA374929 - Sequence 247 from Patent EP2322616.
JC221772 - Sequence 247 from Patent EP2471923.
JC268338 - Sequence 247 from Patent EP2471924.
JC340646 - Sequence 247 from Patent EP2471922.
JC469892 - Sequence 247 from Patent EP2471921.
JC990681 - Sequence 247 from Patent EP2808390.
LF714784 - JP 2016165292-A/247: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
LF856718 - JP 2015142597-A/247: METHODS AND COMPOSITIONS INVOLVING MicroRNA.
CS266363 - Sequence 55 from Patent WO2005118806.
DL076525 - METHODS AND COMPOSITIONS INVOLVING MicroRNA.
DM004175 - METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
FU261110 - MICRORNA EXPRESSION ABNORMALITIES IN PANCREATIC ENDOCRINE AND ACINAR TUMORS.
FU763612 - MICRORNA FINGERPRINTS DURING HUMAN MEGAKARYOCYTOPOIESIS.
FV525893 - Nucleic acid controling mast cell degranulation.
FW361129 - MIR-15, MIR -26, MIR -31, MIR -145, MIR -147, MIR -188, MIR -215, MIR -216, MIR -331, MMU-MIR-292-3P REGULATED GENES AND PATHWAYS AS TARGETS FOR THERAPEUTIC INTERVENTION.
FW421517 - METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
HV304511 - JP 2009531018-A/78: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS, PROGNOSIS AND TREATMENT OF LUNG CANCER.
HV305009 - JP 2009531019-A/78: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF SOLID CANCERS.
HV775532 - JP 2012511031-A/2: COMPOSITIONS AND METHODS RELATING TO miR-31.
HV970137 - JP 2012523000-A/24: Method for in vitro Diagnosing a Complex Disease.
HW102014 - JP 2013500034-A/141: Use of microRNA for treating diseases associated with a dysfunction of the cilia in multiciliated epithelial cells.
HW119218 - JP 2013046612-A/78: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF SOLID CANCERS.
HW349990 - JP 2013534908-A/3: COMPOSITIONS FOR USE IN TREATING OR PREVENTING BONE DISORDERS AND/OR CARDIOVASCULAR DISORDERS.
HW367388 - JP 2012228254-A/55: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
HW411781 - JP 2014000079-A/55: METHODS AND COMPOSITIONS INVOLVING MicroRNA.
HW505117 - JP 2014502606-A/19: MELANOMA TREATMENTS.
HW589547 - JP 2013121348-A/78: MICRORNA FINGERPRINTS DURING HUMAN MEGAKARYOCYTOPOIESIS.
HW674127 - JP 2014217381-A/55: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
HW799346 - WO 2014200065-A/1: Composition for treatment or diagnosis of a colon cancer and use thereof.
HZ043213 - JP 2015510401-A/303: MESENCHYMAL STEM CELLS FOR IN VITRO MODELING AND CELL-BASED THERAPY OF HUMAN DISEASES AND BANKS THEREOF.
HZ043227 - JP 2015510401-A/317: MESENCHYMAL STEM CELLS FOR IN VITRO MODELING AND CELL-BASED THERAPY OF HUMAN DISEASES AND BANKS THEREOF.
HZ067069 - JP 2014012020-A/55: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
HZ081839 - JP 2015514392-A/303: MicroRNAS FOR THE GENERATION OF ASTROCYTES.
HZ081853 - JP 2015514392-A/317: MicroRNAS FOR THE GENERATION OF ASTROCYTES.
HZ408229 - JP 2015528002-A/826: CHIRAL CONTROL.
HZ413351 - JP 2014060993-A/78: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF SOLID CANCERS.
HZ427493 - JP 2014217384-A/55: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
HZ428296 - JP 2014217385-A/55: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
HZ429099 - JP 2014217386-A/55: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
HZ429902 - JP 2014217387-A/55: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
HZ431877 - JP 2014221834-A/2: COMPOSITIONS AND METHODS RELATING TO miR-31.
HZ501562 - JP 2016025853-A/78: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF SOLID CANCERS.
HZ769159 - JP 2014223080-A/55: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
JA058553 - Sequence 55 from Patent EP2298893.
JA059356 - Sequence 55 from Patent EP2298894.
JA073679 - Sequence 55 from Patent EP2281887.
JA104816 - Sequence 55 from Patent EP2302051.
JA106156 - Sequence 55 from Patent EP2302052.
JA106959 - Sequence 55 from Patent EP2302053.
JA107762 - Sequence 55 from Patent EP2302054.
JA108565 - Sequence 55 from Patent EP2302055.
JA109368 - Sequence 55 from Patent EP2302056.
JA191884 - Sequence 55 from Patent EP2290066.
JA192783 - Sequence 55 from Patent EP2290067.
JA193682 - Sequence 55 from Patent EP2290068.
JA194581 - Sequence 55 from Patent EP2290069.
JA195480 - Sequence 55 from Patent EP2290070.
JA196379 - Sequence 55 from Patent EP2290071.
JA197278 - Sequence 55 from Patent EP2290072.
JA198177 - Sequence 55 from Patent EP2290073.
JA199076 - Sequence 55 from Patent EP2290074.
JA199975 - Sequence 55 from Patent EP2290075.
JA200874 - Sequence 55 from Patent EP2290076.
JA217996 - Sequence 55 from Patent EP2281888.
JA226147 - Sequence 55 from Patent EP2292755.
JA229002 - Sequence 55 from Patent EP2292756.
JA257273 - Sequence 55 from Patent EP2284265.
JA278553 - Sequence 55 from Patent EP2281886.
JA284439 - Sequence 55 from Patent EP2281889.
JA292492 - Sequence 55 from Patent EP2287303.
JA317678 - Sequence 55 from Patent EP2314688.
JA374737 - Sequence 55 from Patent EP2322616.
JA525928 - Sequence 78 from Patent EP2369011.
JA526435 - Sequence 78 from Patent EP2369012.
JA526942 - Sequence 78 from Patent EP2369013.
JA535871 - Sequence 78 from Patent EP2371971.
JA642944 - Sequence 2 from Patent EP2370091.
JA682687 - Sequence 3 from Patent WO2011144761.
JA787876 - Sequence 78 from Patent EP2479285.
JA788374 - Sequence 78 from Patent EP2479286.
JA810708 - Sequence 78 from Patent EP2468890.
JA811206 - Sequence 78 from Patent EP2468891.
JA811704 - Sequence 78 from Patent EP2468893.
JA812202 - Sequence 78 from Patent EP2468894.
JA812700 - Sequence 78 from Patent EP2468895.
JA813198 - Sequence 78 from Patent EP2468896.
JA813696 - Sequence 78 from Patent EP2468897.
JA814194 - Sequence 78 from Patent EP2468898.
JA814692 - Sequence 78 from Patent EP2468899.
JA816935 - Sequence 78 from Patent EP2468892.
JA825747 - Sequence 78 from Patent EP2471956.
JA826245 - Sequence 78 from Patent EP2471958.
JB024532 - Sequence 78 from Patent EP2505668.
JB025030 - Sequence 78 from Patent EP2505669.
JB079417 - Sequence 78 from Patent EP2487252.
JB079915 - Sequence 78 from Patent EP2487253.
JB080413 - Sequence 78 from Patent EP2487254.
JB080911 - Sequence 78 from Patent EP2487255.
JB081409 - Sequence 78 from Patent EP2487256.
JB081907 - Sequence 78 from Patent EP2487257.
JB082405 - Sequence 78 from Patent EP2487258.
JB082903 - Sequence 78 from Patent EP2487259.
JB083401 - Sequence 78 from Patent EP2487260.
JB083899 - Sequence 78 from Patent EP2487261.
JB084397 - Sequence 78 from Patent EP2487262.
JB084895 - Sequence 78 from Patent EP2487263.
JB087573 - Sequence 78 from Patent EP2502630.
JB147777 - Sequence 78 from Patent EP2484782.
JB148275 - Sequence 78 from Patent EP2484783.
JB153000 - Sequence 78 from Patent EP2514433.
JB153498 - Sequence 78 from Patent EP2514434.
JB622087 - Sequence 78 from Patent EP2586454.
JB622585 - Sequence 78 from Patent EP2586455.
JC001648 - Sequence 78 from Patent EP2591794.
JC037589 - Sequence 117 from Patent EP2643479.
JC221580 - Sequence 55 from Patent EP2471923.
JC268146 - Sequence 55 from Patent EP2471924.
JC340454 - Sequence 55 from Patent EP2471922.
JC469700 - Sequence 55 from Patent EP2471921.
JC990489 - Sequence 55 from Patent EP2808390.
LF404310 - JP 2015509366-A/303: GENERATION OF NEURAL STEM CELLS AND MOTOR NEURONS.
LF404324 - JP 2015509366-A/317: GENERATION OF NEURAL STEM CELLS AND MOTOR NEURONS.
LF706981 - JP 2016169158-A/1: Composition for treatment or diagnosis of a colon cancer and use thereof.
LF714592 - JP 2016165292-A/55: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
LF856526 - JP 2015142597-A/55: METHODS AND COMPOSITIONS INVOLVING MicroRNA.
LG051563 - KR 1020150036642-A/829: CHIRAL CONTROL.
LQ580781 - Sequence 2 from Patent WO2016102939.
MA353841 - JP 2018075017-A/303: GENERATION OF NEURAL STEM CELLS AND MOTOR NEURONS.
MA353855 - JP 2018075017-A/317: GENERATION OF NEURAL STEM CELLS AND MOTOR NEURONS.
MP045481 - Sequence 303 from Patent EP3401394.
MP045495 - Sequence 317 from Patent EP3401394.
MP084151 - Sequence 303 from Patent EP3401393.
MP084165 - Sequence 317 from Patent EP3401393.
HW350013 - JP 2013534908-A/26: COMPOSITIONS FOR USE IN TREATING OR PREVENTING BONE DISORDERS AND/OR CARDIOVASCULAR DISORDERS.
JA682710 - Sequence 26 from Patent WO2011144761.
HW350015 - JP 2013534908-A/28: COMPOSITIONS FOR USE IN TREATING OR PREVENTING BONE DISORDERS AND/OR CARDIOVASCULAR DISORDERS.
JA682712 - Sequence 28 from Patent WO2011144761.
HW350014 - JP 2013534908-A/27: COMPOSITIONS FOR USE IN TREATING OR PREVENTING BONE DISORDERS AND/OR CARDIOVASCULAR DISORDERS.
JA682711 - Sequence 27 from Patent WO2011144761.
HW350010 - JP 2013534908-A/23: COMPOSITIONS FOR USE IN TREATING OR PREVENTING BONE DISORDERS AND/OR CARDIOVASCULAR DISORDERS.
JA682707 - Sequence 23 from Patent WO2011144761.
FW364210 - Oligonucleotides for modulating target RNA activity.
HI560872 - Sequence 87 from Patent EP2190992.
HI965190 - Sequence 475 from Patent WO2010139812.
HI965897 - Sequence 217 from Patent WO2010139811.
HI966763 - Sequence 217 from Patent WO2010139810.
HV593973 - JP 2010538653-A/87: MIRNA EXPRESSION IN HUMAN PERIPHERAL BLOOD MICROVESICLES AND USES THEREOF.
HV595116 - JP 2010539959-A/497: Micromirs.
HW101962 - JP 2013500034-A/89: Use of microRNA for treating diseases associated with a dysfunction of the cilia in multiciliated epithelial cells.
HW350011 - JP 2013534908-A/24: COMPOSITIONS FOR USE IN TREATING OR PREVENTING BONE DISORDERS AND/OR CARDIOVASCULAR DISORDERS.
HW505486 - JP 2014502606-A/388: MELANOMA TREATMENTS.
HW812557 - JP 2014533960-A/1: A method for predicting responsiveness to a treatment with an EGFR inhibitor.
HZ073963 - JP 2013535982-A/54: Single-Stranded RNAi Agents Containing an Internal, Non-Nucleic Acid Spacer.
HZ082815 - JP 2015513906-A/172: Stem Cell Microparticles.
HZ157673 - JP 2015130862-A/497: Micromirs.
HZ186523 - JP 2015146814-A/272: Oligonucleotides for modulating target RNA activity.
HZ436596 - JP 2015529450-A/172: Stem Cell Microparticles.
HZ480105 - JP 2015535430-A/611: TERMINALLY MODIFIED RNA.
HZ790036 - JP 2016504050-A/1781: SIGNAL-SENSOR POLYNUCLEOTIDES FOR THE ALTERATION OF CELLULAR PHENOTYPES.
JA287407 - Sequence 89 from Patent WO2011015720.
JA401228 - Sequence 475 from Patent WO2011080318.
JA402206 - Sequence 475 from Patent WO2011080315.
JA403213 - Sequence 475 from Patent WO2011080316.
JA405844 - Sequence 475 from Patent EP2336353.
JA426745 - Sequence 78 from Patent WO2011072177.
JA429370 - Sequence 475 from Patent WO2011095623.
JA660563 - Sequence 17 from Patent WO2011131354.
JA682607 - Sequence 75 from Patent WO2011149354.
JA682708 - Sequence 24 from Patent WO2011144761.
JA791883 - Sequence 285 from Patent WO2012089772.
JA791975 - Sequence 24 from Patent WO2012089753.
JB022290 - Sequence 132 from Patent WO2013026685.
JB022876 - Sequence 130 from Patent WO2013026684.
JB049930 - Sequence 17 from Patent WO2013020926.
JB175062 - Sequence 94 from Patent WO2012101219.
JB620061 - Sequence 41 from Patent WO2013063544.
JB620138 - Sequence 118 from Patent WO2013063544.
JB624267 - Sequence 87 from Patent EP2610342.
JB779403 - Sequence 1 from Patent WO2013076282.
JC037777 - Sequence 305 from Patent EP2643479.
JC171800 - Sequence 172 from Patent WO2013150303.
JC512768 - Sequence 3021 from Patent WO2014113089.
JC572611 - Sequence 172 from Patent WO2014125276.
JC582299 - Sequence 172 from Patent WO2014125277.
JE953995 - Sequence 172 from Patent WO2015052526.
JE955748 - Sequence 172 from Patent WO2015052527.
JE978572 - Sequence 17 from Patent EP2865765.
LF137500 - JP 2016507550-A/172: Method of Producing Microparticles.
LF161408 - JP 2016513950-A/1474: Oligomers with improved off-target profile.
LF162465 - JP 2016513095-A/172: Stem Cell Microparticles and miRNA.
LF636239 - JP 2016519076-A/13: COMBINATION CANCER TREATMENTS UTILIZING MICRORNA AND EGFR-TKI INHIBITORS.
LF953217 - JP 2016534103-A/172: Stem Cell Microparticles and miRNA.
LG005562 - KR 1020150004822-A/172: STEM CELL MICROPARTICLES.
LG053258 - KR 1020150059168-A/172: STEM CELL MICROPARTICLES.
LG134396 - KR 1020150131312-A/13: COMBINATION CANCER TREATMENTS UTILIZING MICRORNAS AND EGFR-TKI INHIBITORS.
LG240497 - KR 1020160035087-A/172: STEM CELL MICROPARTICLES AND MIRNA.
LP726523 - Sequence 217 from Patent EP2883966.
LP818793 - Sequence 217 from Patent EP3296406.
LP896973 - Sequence 1837 from Patent EP3253886.
LP938735 - Sequence 217 from Patent EP3184651.
LQ070356 - Sequence 680 from Patent EP2964234.
LQ251602 - Sequence 1 from Patent EP3000895.
LQ278480 - Sequence 19 from Patent WO2016066288.
LQ302663 - Sequence 1 from Patent WO2016046365.
LQ420483 - Sequence 59 from Patent WO2016127998.
LV470582 - JP 2016534036-A/172: Stem Cell Microparticles and miRNA.
LX080476 - JP 2017503478-A/1: A method for predicting responsiveness to a treatment with an EGFR inhibitor.
LY336226 - KR 1020160089488-A/1: A METHOD FOR PREDICTING RESPONSIVENESS TO A TREATMENT WITH AN EGFR INHIBITOR.
LY405181 - KR 1020160117535-A/486: POLY OLIGOMER COMPOUND WITH BIOCLEAVABLE CONJUGATES.
LZ233880 - JP 2017184756-A/272: Oligonucleotides for modulating target RNA activity.
MA260420 - JP 2017505623-A/486: POLY OLIGOMER COMPOUND WITH BIOCLEAVABLE CONJUGATES.
MA643857 - JP 2017113010-A/1781: SIGNAL-SENSOR POLYNUCLEOTIDES FOR THE ALTERATION OF CELLULAR PHENOTYPES.
MA731741 - JP 2017140048-A/611: TERMINALLY MODIFIED RNA.
MS673327 - Sequence 130 from Patent EP3135774.
MS833382 - Sequence 87 from Patent EP3112464.
MS834329 - Sequence 475 from Patent EP3112479.
MS901659 - Sequence 132 from Patent EP3156505.
HW350012 - JP 2013534908-A/25: COMPOSITIONS FOR USE IN TREATING OR PREVENTING BONE DISORDERS AND/OR CARDIOVASCULAR DISORDERS.
JA682709 - Sequence 25 from Patent WO2011144761.
HI979103 - Sequence 30 from Patent EP2234483.
HV342485 - JP 2011510623-A/30: METHODS AND COMPOSITIONS FOR DIAGNOSING COMPLICATIONS OF PREGNANCY.
HW350008 - JP 2013534908-A/21: COMPOSITIONS FOR USE IN TREATING OR PREVENTING BONE DISORDERS AND/OR CARDIOVASCULAR DISORDERS.
HW799360 - WO 2014200065-A/15: Composition for treatment or diagnosis of a colon cancer and use thereof.
JA682705 - Sequence 21 from Patent WO2011144761.
LF706995 - JP 2016169158-A/15: Composition for treatment or diagnosis of a colon cancer and use thereof.
HW350002 - JP 2013534908-A/15: COMPOSITIONS FOR USE IN TREATING OR PREVENTING BONE DISORDERS AND/OR CARDIOVASCULAR DISORDERS.
HW799355 - WO 2014200065-A/10: Composition for treatment or diagnosis of a colon cancer and use thereof.
JA682699 - Sequence 15 from Patent WO2011144761.
LF706990 - JP 2016169158-A/10: Composition for treatment or diagnosis of a colon cancer and use thereof.
HW799347 - WO 2014200065-A/2: Composition for treatment or diagnosis of a colon cancer and use thereof.
LF706982 - JP 2016169158-A/2: Composition for treatment or diagnosis of a colon cancer and use thereof.
HW350009 - JP 2013534908-A/22: COMPOSITIONS FOR USE IN TREATING OR PREVENTING BONE DISORDERS AND/OR CARDIOVASCULAR DISORDERS.
HW799361 - WO 2014200065-A/16: Composition for treatment or diagnosis of a colon cancer and use thereof.
JA682706 - Sequence 22 from Patent WO2011144761.
LF706996 - JP 2016169158-A/16: Composition for treatment or diagnosis of a colon cancer and use thereof.
HW349998 - JP 2013534908-A/11: COMPOSITIONS FOR USE IN TREATING OR PREVENTING BONE DISORDERS AND/OR CARDIOVASCULAR DISORDERS.
HW799351 - WO 2014200065-A/6: Composition for treatment or diagnosis of a colon cancer and use thereof.
JA682695 - Sequence 11 from Patent WO2011144761.
LF706986 - JP 2016169158-A/6: Composition for treatment or diagnosis of a colon cancer and use thereof.
AJ421753 - Homo sapiens microRNA miR-31.
CQ873619 - Sequence 38 from Patent WO2004076622.
CS166326 - Sequence 37 from Patent WO2005078096.
CS265296 - Sequence 38 from Patent EP1627925.
CS444351 - Sequence 38 from Patent WO2006108473.
CS548396 - Sequence 1426 from Patent EP1777301.
DD413456 - Regulation of Mammalian Cells.
DJ003826 - Method for predicting or identifying target mRNAs of functional RNAs and use thereof.
DJ027105 - Method for predicting or identifying target mRNAs of functional RNAs and use thereof.
DL231868 - Method for the determination of cellular transcriptional regulation.
DL233853 - Identification of novel genes encoding for small temporal RNA.
FU261385 - MICRORNA EXPRESSION ABNORMALITIES IN PANCREATIC ENDOCRINE AND ACINAR TUMORS.
FU763887 - MICRORNA FINGERPRINTS DURING HUMAN MEGAKARYOCYTOPOIESIS.
FV523082 - Identification of novel genes encoding for small temporal RNA.
FV523898 - Diagnosis and therapeutic choice of head and neck tumor using micro RNA as biomarker.
FV524339 - Nucleic acid controling mast cell degranulation.
FW312137 - DETECTING NUCLEIC ACIDS.
FW342821 - Diagnosis and therapeutic choice of head and neck tumor using micro RNA as biomarker.
FW360940 - MIR-15, MIR -26, MIR -31, MIR -145, MIR -147, MIR -188, MIR -215, MIR -216, MIR -331, MMU-MIR-292-3P REGULATED GENES AND PATHWAYS AS TARGETS FOR THERAPEUTIC INTERVENTION.
FW571148 - WO 2010119698-A/8: Head and neck tumor growth suppressant.
HI979078 - Sequence 5 from Patent EP2234483.
HV304786 - JP 2009531018-A/353: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS, PROGNOSIS AND TREATMENT OF LUNG CANCER.
HV305284 - JP 2009531019-A/353: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF SOLID CANCERS.
HV342460 - JP 2011510623-A/5: METHODS AND COMPOSITIONS FOR DIAGNOSING COMPLICATIONS OF PREGNANCY.
HW119493 - JP 2013046612-A/353: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF SOLID CANCERS.
HW350006 - JP 2013534908-A/19: COMPOSITIONS FOR USE IN TREATING OR PREVENTING BONE DISORDERS AND/OR CARDIOVASCULAR DISORDERS.
HW530038 - JP 2014094008-A/99: Identification of novel genes encoding for small temporal RNA.
HW589822 - JP 2013121348-A/353: MICRORNA FINGERPRINTS DURING HUMAN MEGAKARYOCYTOPOIESIS.
HW799358 - WO 2014200065-A/13: Composition for treatment or diagnosis of a colon cancer and use thereof.
HZ413626 - JP 2014060993-A/353: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF SOLID CANCERS.
HZ501837 - JP 2016025853-A/353: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF SOLID CANCERS.
JA526203 - Sequence 353 from Patent EP2369011.
JA526710 - Sequence 353 from Patent EP2369012.
JA527217 - Sequence 353 from Patent EP2369013.
JA536146 - Sequence 353 from Patent EP2371971.
JA641979 - Sequence 99 from Patent EP2386637.
JA663264 - Sequence 99 from Patent EP2385122.
JA663481 - Sequence 99 from Patent EP2385123.
JA682703 - Sequence 19 from Patent WO2011144761.
JA788151 - Sequence 353 from Patent EP2479285.
JA788649 - Sequence 353 from Patent EP2479286.
JA810983 - Sequence 353 from Patent EP2468890.
JA811481 - Sequence 353 from Patent EP2468891.
JA811979 - Sequence 353 from Patent EP2468893.
JA812477 - Sequence 353 from Patent EP2468894.
JA812975 - Sequence 353 from Patent EP2468895.
JA813473 - Sequence 353 from Patent EP2468896.
JA813971 - Sequence 353 from Patent EP2468897.
JA814469 - Sequence 353 from Patent EP2468898.
JA814967 - Sequence 353 from Patent EP2468899.
JA817210 - Sequence 353 from Patent EP2468892.
JA826022 - Sequence 353 from Patent EP2471956.
JA826520 - Sequence 353 from Patent EP2471958.
JB024807 - Sequence 353 from Patent EP2505668.
JB025305 - Sequence 353 from Patent EP2505669.
JB079692 - Sequence 353 from Patent EP2487252.
JB080190 - Sequence 353 from Patent EP2487253.
JB080688 - Sequence 353 from Patent EP2487254.
JB081186 - Sequence 353 from Patent EP2487255.
JB081684 - Sequence 353 from Patent EP2487256.
JB082182 - Sequence 353 from Patent EP2487257.
JB082680 - Sequence 353 from Patent EP2487258.
JB083178 - Sequence 353 from Patent EP2487259.
JB083676 - Sequence 353 from Patent EP2487260.
JB084174 - Sequence 353 from Patent EP2487261.
JB084672 - Sequence 353 from Patent EP2487262.
JB085170 - Sequence 353 from Patent EP2487263.
JB087848 - Sequence 353 from Patent EP2502630.
JB148052 - Sequence 353 from Patent EP2484782.
JB148550 - Sequence 353 from Patent EP2484783.
JB153275 - Sequence 353 from Patent EP2514433.
JB153773 - Sequence 353 from Patent EP2514434.
JB292061 - Sequence 99 from Patent EP2428569.
JB302176 - Sequence 99 from Patent EP2428570.
JB320131 - Sequence 99 from Patent EP2428568.
JB336194 - Sequence 99 from Patent EP2428571.
JB361381 - Sequence 99 from Patent EP2428567.
JB622362 - Sequence 353 from Patent EP2586454.
JB622860 - Sequence 353 from Patent EP2586455.
JC001923 - Sequence 353 from Patent EP2591794.
JC334226 - Sequence 144 from Patent EP2487240.
LF706993 - JP 2016169158-A/13: Composition for treatment or diagnosis of a colon cancer and use thereof.
LP637003 - Sequence 53 from Patent EP2848702.
HW349997 - JP 2013534908-A/10: COMPOSITIONS FOR USE IN TREATING OR PREVENTING BONE DISORDERS AND/OR CARDIOVASCULAR DISORDERS.
HW799350 - WO 2014200065-A/5: Composition for treatment or diagnosis of a colon cancer and use thereof.
JA682694 - Sequence 10 from Patent WO2011144761.
LF706985 - JP 2016169158-A/5: Composition for treatment or diagnosis of a colon cancer and use thereof.
MS816815 - Sequence 164 from Patent WO2017085287.
FZ436973 - JP 2011501966-A/20: PROCESS FOR MONITORING COLORECTAL CANCER.
HW350007 - JP 2013534908-A/20: COMPOSITIONS FOR USE IN TREATING OR PREVENTING BONE DISORDERS AND/OR CARDIOVASCULAR DISORDERS.
HW799359 - WO 2014200065-A/14: Composition for treatment or diagnosis of a colon cancer and use thereof.
JA682704 - Sequence 20 from Patent WO2011144761.
LF706994 - JP 2016169158-A/14: Composition for treatment or diagnosis of a colon cancer and use thereof.
FW364209 - Oligonucleotides for modulating target RNA activity.
FZ414381 - WO 2011007815-A/271: A method for screening a food which promotes production of milk having immunoregulating effect.
HI560871 - Sequence 86 from Patent EP2190992.
HI929401 - Sequence 8 from Patent EP2258863.
HI953427 - Sequence 3 from Patent WO2010136417.
HI965191 - Sequence 476 from Patent WO2010139812.
HI966106 - Sequence 426 from Patent WO2010139811.
HI966972 - Sequence 426 from Patent WO2010139810.
HV511979 - JP 2011520454-A/94: Methods for Assessing Colorectal Cancer and Compositions for use therein.
HV593972 - JP 2010538653-A/86: MIRNA EXPRESSION IN HUMAN PERIPHERAL BLOOD MICROVESICLES AND USES THEREOF.
HV595115 - JP 2010539959-A/496: Micromirs.
HV775531 - JP 2012511031-A/1: COMPOSITIONS AND METHODS RELATING TO miR-31.
HV821909 - JP 2011140513-A/271: An Immunostimulating pharmaceutical composition, and a method for producing the immunostimulating pharmaceutical composition.
HV953959 - JP 2012518421-A/871: METHODS OF DETECTING LUNG CANCER.
HW101910 - JP 2013500034-A/37: Use of microRNA for treating diseases associated with a dysfunction of the cilia in multiciliated epithelial cells.
HW349988 - JP 2013534908-A/1: COMPOSITIONS FOR USE IN TREATING OR PREVENTING BONE DISORDERS AND/OR CARDIOVASCULAR DISORDERS.
HW349999 - JP 2013534908-A/12: COMPOSITIONS FOR USE IN TREATING OR PREVENTING BONE DISORDERS AND/OR CARDIOVASCULAR DISORDERS.
HW505306 - JP 2014502606-A/208: MELANOMA TREATMENTS.
HW523312 - JP 2014507123-A/97: BLOOD-BORNE MIRNAS AS SURROGATE MARKERS OF DRUG EFFICACY FOR CARDIAC CONDITIONS.
HW669805 - JP 2013537538-A/536: THERAPEUTIC USES OF MICROVESICLES AND RELATED MICRORNAS.
HW799352 - WO 2014200065-A/7: Composition for treatment or diagnosis of a colon cancer and use thereof.
HZ043104 - JP 2015510401-A/194: MESENCHYMAL STEM CELLS FOR IN VITRO MODELING AND CELL-BASED THERAPY OF HUMAN DISEASES AND BANKS THEREOF.
HZ043118 - JP 2015510401-A/208: MESENCHYMAL STEM CELLS FOR IN VITRO MODELING AND CELL-BASED THERAPY OF HUMAN DISEASES AND BANKS THEREOF.
HZ073962 - JP 2013535982-A/53: Single-Stranded RNAi Agents Containing an Internal, Non-Nucleic Acid Spacer.
HZ081730 - JP 2015514392-A/194: MicroRNAS FOR THE GENERATION OF ASTROCYTES.
HZ081744 - JP 2015514392-A/208: MicroRNAS FOR THE GENERATION OF ASTROCYTES.
HZ082723 - JP 2015513906-A/80: Stem Cell Microparticles.
HZ157672 - JP 2015130862-A/496: Micromirs.
HZ186522 - JP 2015146814-A/271: Oligonucleotides for modulating target RNA activity.
HZ431876 - JP 2014221834-A/1: COMPOSITIONS AND METHODS RELATING TO miR-31.
HZ436504 - JP 2015529450-A/80: Stem Cell Microparticles.
HZ480137 - JP 2015535430-A/643: TERMINALLY MODIFIED RNA.
HZ790068 - JP 2016504050-A/1813: SIGNAL-SENSOR POLYNUCLEOTIDES FOR THE ALTERATION OF CELLULAR PHENOTYPES.
JA287355 - Sequence 37 from Patent WO2011015720.
JA401229 - Sequence 476 from Patent WO2011080318.
JA402207 - Sequence 476 from Patent WO2011080315.
JA403214 - Sequence 476 from Patent WO2011080316.
JA405845 - Sequence 476 from Patent EP2336353.
JA426899 - Sequence 232 from Patent WO2011072177.
JA429371 - Sequence 476 from Patent WO2011095623.
JA483459 - Sequence 94 from Patent EP2283161.
JA642943 - Sequence 1 from Patent EP2370091.
JA682543 - Sequence 11 from Patent WO2011149354.
JA682685 - Sequence 1 from Patent WO2011144761.
JA682696 - Sequence 12 from Patent WO2011144761.
JA715089 - Sequence 871 from Patent EP2401406.
JA792018 - Sequence 67 from Patent WO2012089753.
JA885467 - Sequence 97 from Patent WO2012083004.
JB022353 - Sequence 195 from Patent WO2013026685.
JB073535 - Sequence 8 from Patent EP2546361.
JB149196 - Sequence 271 from Patent EP2455486.
JB175099 - Sequence 131 from Patent WO2012101219.
JB615291 - Sequence 13 from Patent WO2013070079.
JB616196 - Sequence 26 from Patent WO2013107459.
JB620038 - Sequence 18 from Patent WO2013063544.
JB620137 - Sequence 117 from Patent WO2013063544.
JB624266 - Sequence 86 from Patent EP2610342.
JB733787 - Sequence 3190 from Patent WO2013082448.
JB835731 - Sequence 21 from Patent WO2013057567.
JC023887 - Sequence 403 from Patent EP2641976.
JC037521 - Sequence 49 from Patent EP2643479.
JC171708 - Sequence 80 from Patent WO2013150303.
JC244885 - Sequence 513 from Patent WO2012020308.
JC244958 - Sequence 586 from Patent WO2012020308.
JC270145 - Sequence 536 from Patent WO2012020307.
JC512800 - Sequence 3053 from Patent WO2014113089.
JC572519 - Sequence 80 from Patent WO2014125276.
JC582207 - Sequence 80 from Patent WO2014125277.
JE953903 - Sequence 80 from Patent WO2015052526.
JE955656 - Sequence 80 from Patent WO2015052527.
LF137408 - JP 2016507550-A/80: Method of Producing Microparticles.
LF160580 - JP 2016513950-A/646: Oligomers with improved off-target profile.
LF162373 - JP 2016513095-A/80: Stem Cell Microparticles and miRNA.
LF404201 - JP 2015509366-A/194: GENERATION OF NEURAL STEM CELLS AND MOTOR NEURONS.
LF404215 - JP 2015509366-A/208: GENERATION OF NEURAL STEM CELLS AND MOTOR NEURONS.
LF636252 - JP 2016519076-A/26: COMBINATION CANCER TREATMENTS UTILIZING MICRORNA AND EGFR-TKI INHIBITORS.
LF706987 - JP 2016169158-A/7: Composition for treatment or diagnosis of a colon cancer and use thereof.
LF953125 - JP 2016534103-A/80: Stem Cell Microparticles and miRNA.
LG005470 - KR 1020150004822-A/80: STEM CELL MICROPARTICLES.
LG053166 - KR 1020150059168-A/80: STEM CELL MICROPARTICLES.
LG134409 - KR 1020150131312-A/26: COMBINATION CANCER TREATMENTS UTILIZING MICRORNAS AND EGFR-TKI INHIBITORS.
LG240405 - KR 1020160035087-A/80: STEM CELL MICROPARTICLES AND MIRNA.
LP726732 - Sequence 426 from Patent EP2883966.
LP819002 - Sequence 426 from Patent EP3296406.
LP896679 - Sequence 1543 from Patent EP3253886.
LP938944 - Sequence 426 from Patent EP3184651.
LP951914 - Sequence 420 from Patent WO2017157650.
LQ070388 - Sequence 712 from Patent EP2964234.
LQ251603 - Sequence 2 from Patent EP3000895.
LQ302664 - Sequence 2 from Patent WO2016046365.
LQ420484 - Sequence 60 from Patent WO2016127998.
LV470490 - JP 2016534036-A/80: Stem Cell Microparticles and miRNA.
LX270602 - JP 2016056210-A/536: THERAPEUTIC USES OF MICROVESICLES AND RELATED MICRORNAS.
LY405180 - KR 1020160117535-A/485: POLY OLIGOMER COMPOUND WITH BIOCLEAVABLE CONJUGATES.
LY489857 - KR 1020170046253-A/5: Method for Evaluating Compound Toxicity Using Exosome Biomarker.
LZ233879 - JP 2017184756-A/271: Oligonucleotides for modulating target RNA activity.
MA260419 - JP 2017505623-A/485: POLY OLIGOMER COMPOUND WITH BIOCLEAVABLE CONJUGATES.
MA267359 - JP 2018061445-A/93: Method for detecting urothelial cancer based on microRNA in urine using cell sorting.
MA353732 - JP 2018075017-A/194: GENERATION OF NEURAL STEM CELLS AND MOTOR NEURONS.
MA353746 - JP 2018075017-A/208: GENERATION OF NEURAL STEM CELLS AND MOTOR NEURONS.
MA643889 - JP 2017113010-A/1813: SIGNAL-SENSOR POLYNUCLEOTIDES FOR THE ALTERATION OF CELLULAR PHENOTYPES.
MA730749 - JP 2017125065-A/536: THERAPEUTIC USES OF MICROVESICLES AND RELATED MICRORNAS.
MA731773 - JP 2017140048-A/643: TERMINALLY MODIFIED RNA.
MP045372 - Sequence 194 from Patent EP3401394.
MP045386 - Sequence 208 from Patent EP3401394.
MP075748 - Sequence 87 from Patent WO2019002265.
MP084042 - Sequence 194 from Patent EP3401393.
MP084056 - Sequence 208 from Patent EP3401393.
MS833381 - Sequence 86 from Patent EP3112464.
MS834330 - Sequence 476 from Patent EP3112479.
MS901722 - Sequence 195 from Patent EP3156505.
HW349996 - JP 2013534908-A/9: COMPOSITIONS FOR USE IN TREATING OR PREVENTING BONE DISORDERS AND/OR CARDIOVASCULAR DISORDERS.
HW799349 - WO 2014200065-A/4: Composition for treatment or diagnosis of a colon cancer and use thereof.
JA682693 - Sequence 9 from Patent WO2011144761.
LF706984 - JP 2016169158-A/4: Composition for treatment or diagnosis of a colon cancer and use thereof.
HW350000 - JP 2013534908-A/13: COMPOSITIONS FOR USE IN TREATING OR PREVENTING BONE DISORDERS AND/OR CARDIOVASCULAR DISORDERS.
HW799353 - WO 2014200065-A/8: Composition for treatment or diagnosis of a colon cancer and use thereof.
JA682697 - Sequence 13 from Patent WO2011144761.
LF706988 - JP 2016169158-A/8: Composition for treatment or diagnosis of a colon cancer and use thereof.
MA800910 - JP 2018183181-A/1781: SIGNAL-SENSOR POLYNUCLEOTIDES FOR THE ALTERATION OF CELLULAR PHENOTYPES.
MA800942 - JP 2018183181-A/1813: SIGNAL-SENSOR POLYNUCLEOTIDES FOR THE ALTERATION OF CELLULAR PHENOTYPES.
MP129272 - Sequence 172 from Patent EP3470073.
MP162195 - Sequence 172 from Patent WO2019069093.
MP129180 - Sequence 80 from Patent EP3470073.
MP162103 - Sequence 80 from Patent WO2019069093.
MA867087 - JP 2018537983-A/106: COMPOSITIONS AND METHODS FOR THE DIAGNOSIS AND TREATMENT OF BONE FRACTURES AND DISORDERS.
MA989791 - JP 2017529852-A/1: A method for predicting responsiveness to a treatment with an EGFR inhibitor.
MB018430 - JP 2018504915-A/59: A microRNA-based method for early detection of prostate cancer in urine samples.
MA867081 - JP 2018537983-A/100: COMPOSITIONS AND METHODS FOR THE DIAGNOSIS AND TREATMENT OF BONE FRACTURES AND DISORDERS.
MA989792 - JP 2017529852-A/2: A method for predicting responsiveness to a treatment with an EGFR inhibitor.
MB018431 - JP 2018504915-A/60: A microRNA-based method for early detection of prostate cancer in urine samples.
MP280629 - Sequence 49 from Patent WO2019111197.
MP264439 - Sequence 27 from Patent EP3502269.
MP280630 - Sequence 50 from Patent WO2019111197.
MP283542 - Sequence 49 from Patent WO2019111198.
MP283543 - Sequence 50 from Patent WO2019111198.
LY656592 - KR 1020190057529-A/1: The biomarker miRNA-31-5p for diagnosis of pre-eclampsia and use thereof.
LY656594 - KR 1020190057529-A/3: The biomarker miRNA-31-5p for diagnosis of pre-eclampsia and use thereof.
LY656593 - KR 1020190057529-A/2: The biomarker miRNA-31-5p for diagnosis of pre-eclampsia and use thereof.
MB453663 - JP 2018509178-A/229: Methods for Highly Parallel and Accurate Measurement of Nucleic Acids.
MP545952 - Sequence 4 from Patent WO2020030561.
MP328219 - Sequence 3 from Patent EP3543358.
MP330020 - Sequence 3 from Patent WO2019180136.
MP545951 - Sequence 3 from Patent WO2020030561.

-  Other Names for This Gene
  Alternate Gene Symbols: NR_029505, uc011lnj.1, uc011lnj.2
UCSC ID: ENST00000362307.1
RefSeq Accession: NR_029505

-  Methods, Credits, and Use Restrictions
  Click here for details on how this gene model was made and data restrictions if any.